JPMorgan Chase Financial Issues Auto Callable Notes Linked to Russell 2000, S&P 500, and Semiconductor ETF

Structured Product Design and Multi-Index Linkage Strategy

The notes issued by JPMorgan Chase Financial are structured as complex derivative securities with performance tied to three distinct underlyings tracked independently. The underlyings comprise the Russell 2000 Index (Bloomberg ticker RTY), the S&P 500 Index (Bloomberg ticker SPX), and the VanEck Semiconductor ETF (Bloomberg ticker SMH). Rather than using a basket approach where the three assets are combined into a single performance metric, this design links all payments to the least performing of the three underlyings, meaning the worst-performing asset determines investor returns at maturity.

The issuer, JPMorgan Chase Financial Company LLC, is a direct wholly-owned finance subsidiary of JPMorgan Chase & Co., which provides full and unconditional guarantee of all note payments. These notes represent unsecured and unsubordinated obligations of the finance subsidiary, making the creditworthiness of both the issuer and guarantor relevant to investor risk assessment. The structure allows investors to gain synthetic exposure to multiple equity indices and an exchange-traded fund through a single security, though this layered approach introduces complexity in determining final payout values.

Contingent Interest Payment Terms and Barrier Structure

The notes feature contingent monthly interest payments contingent on performance benchmarks tracked quarterly and monthly. According to the disclosure, if the closing value of each underlying on any review date exceeds or equals 65% of its initial value (the interest barrier), investors receive contingent interest payments. The disclosure specifies that contingent interest payments equal at least $10.875 per $1,000 principal amount, equivalent to at least 13.05% per annum or at least 1.0875% per month. Final rates will be disclosed in the pricing supplement upon completion of the offering.

The interest barrier mechanism creates a threshold below which no contingent interest accrues. If the closing value of any single underlying falls below 65% of its initial value on a review date, no contingent interest payment is made for that period. This design penalizes investors for weakness in even one of the three underlyings, since the notes are linked to each underlying individually rather than to a combined basket performance. The disclosure states that investors should be willing to forgo fixed interest and dividend payments in exchange for the conditional opportunity to receive contingent interest, underscoring the trade-off inherent in this product structure.

Automatic Call Feature and Early Redemption Mechanics

The notes incorporate an automatic call feature that triggers redemption at par plus accrued contingent interest if all three underlyings close at or above their initial values on specified review dates. The disclosure indicates that the earliest date on which an automatic call may occur is July 30, 2027, approximately one year after the expected settlement date of August 4, 2026. Notably, automatic calls cannot be triggered on the first through eleventh review dates or on the final maturity review date, restricting the call window to specific periods during the note term.

Upon automatic call, investors receive a cash payment of $1,000 principal per note plus the contingent interest payment applicable to that review date, with settlement occurring on the first interest payment date following the review date triggering the call. The automatic call mechanism means that investors' returns are capped at the contingent interest earned up to the call date if underlying assets recover to initial values. This feature benefits the issuer by allowing early redemption in favorable market conditions but may disadvantage investors by eliminating upside participation once the call threshold is breached.

Principal Risk and Loss Scenarios at Maturity

The disclosure contains explicit warnings about downside risk for note holders. If the notes remain outstanding at maturity on August 4, 2031, and if any underlying's final value falls below 50% of its initial value (the trigger value), investors face return of principal calculated by a formula: $1,000 plus $1,000 multiplied by the least performing underlying return. This formula means that if the worst-performing underlying declines 60% from its initial value, the investor receives only $400 per $1,000 principal invested, realizing a 60% loss.

The disclosure explicitly states that investors will lose more than 50% of principal amount at maturity if any underlying falls below the 50% trigger value, and could lose all principal if an underlying declines 100%. This worst-case scenario creates significant tail risk, particularly given the linkage to the least performing underlying. An investor's return depends not on average performance across the three underlyings, but on whichever performs worst, concentrating downside risk. The disclosure emphasizes that investors must be willing to accept the risk of losing a significant portion or all principal, reflecting the non-traditional risk profile of this structured product.

Review Dates, Interest Payment Schedule, and Maturity Timeline

The notes feature a series of review dates beginning August 31, 2026, and continuing through a final review date in 2031. The disclosure lists specific review dates as August 31, 2026; September 30, 2026; October 30, 2026; November 30, 2026; December 30, 2026; February 1, 2027; March 1, 2027; March 30, 2027; April 30, 2027; June 1, 2027; June 30, 2027; July 30, 2027; August 30, 2027; and September 30, 2027, with additional review dates continuing through maturity. Each review date triggers an assessment of whether underlyings meet the interest barrier threshold and whether automatic call conditions are satisfied.

Interest payment dates correspond to each review date, meaning contingent interest (if earned) is paid monthly throughout the note term. The maturity date is August 4, 2031, exactly five years from the expected settlement date. Review dates and interest payment dates are subject to postponement in the event of market disruption events and may be subject to early acceleration if acceleration events occur as described in accompanying product supplement and prospectus materials. This timeline creates regular assessment points where note performance is evaluated and payments are made or withheld based on underlying asset prices.

Estimated Value and Pricing Information

The preliminary pricing supplement discloses that if the notes priced on the date of the announcement, the estimated value would be approximately $900.90 per $1,000 principal amount note. However, this represents an estimate only, and the final estimated value when terms are formally set will be disclosed in the final pricing supplement. The disclosure specifies that the estimated value will not be less than $900.00 per $1,000 principal amount note, establishing a floor but acknowledging potential variance from the preliminary estimate.

The price to public is established at $1,000 per note in minimum denominations of $1,000 and integral multiples thereof. The disclosure notes that selling commissions paid to dealers will not exceed $41.25 per $1,000 principal amount note, with J.P. Morgan Securities LLC acting as agent to distribute commissions to affiliated or unaffiliated dealers. The spread between the $1,000 offering price and the estimated value of approximately $900.90 reflects the issuer's economics and underwriting compensation embedded in the product pricing.

Expected Pricing and Settlement Dates

According to the disclosure, the notes are expected to price on or about July 30, 2026, with settlement expected to occur on or about August 4, 2026. These dates establish the timeline for initial public distribution and transfer of notes to purchasers. The pricing date of July 30, 2026 also serves as the reference date for establishing the initial values of all three underlyings, meaning the closing values of the Russell 2000, S&P 500, and VanEck Semiconductor ETF on that date become the baseline against which all future payments and returns are measured. The expected settlement date of August 4, 2026 also serves as the original issue date for the notes and is the beginning of the five-year maturity period.

The use of "expected" language in the disclosure reflects the preliminary nature of the pricing supplement, which indicates that terms and conditions remained subject to completion. Actual pricing and settlement dates could differ from these preliminary expectations based on market conditions, regulatory approvals, or other factors affecting the distribution process. The disclosure does not provide certainty regarding final pricing terms beyond the stated minimum estimated value of $900.00 per note.

Underlying Asset Performance Mechanics and Least-Performing Structure

The notes employ a least-performing underlying return calculation that determines investor payout at maturity if no automatic call occurs. The underlying return for each asset is calculated as (final value minus initial value) divided by initial value, expressed as a percentage. The least performing underlying return represents the lowest of these three return calculations, meaning the single worst-performing asset among the three underlyings determines the final payout if that worst performer falls below the 50% trigger value. This structure creates negative convexity for investors, as they benefit from the best-case scenario only if all three underlyings remain above the 50% threshold, but suffer losses based on the worst performer.

The initial value for each underlying is established as the closing value on the pricing date of July 30, 2026, while the final value is the closing value on the final review date in 2031. The VanEck Semiconductor ETF is subject to a share adjustment factor set at 1.0 on the pricing date, with potential adjustments for certain corporate events affecting the fund. The multi-underlying design means investors must monitor performance across three distinct equity markets and one ETF throughout the five-year term, introducing complexity in tracking expected outcomes.

Credit Risk and Guarantee Structure

While the notes are issued by JPMorgan Chase Financial Company LLC, a finance subsidiary, all payments are fully and unconditionally guaranteed by JPMorgan Chase & Co., the parent holding company. This guarantee structure means that investor claims against principal and interest payments are backed by the creditworthiness of both the issuer and the guarantor. The disclosure emphasizes that any payment on the notes remains subject to the credit risk of JPMorgan Financial as issuer and JPMorgan Chase & Co. as guarantor, indicating that the guarantee does not eliminate credit risk but rather extends it to include the guarantor's credit quality.

The notes are explicitly not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of or guaranteed by a bank. This clarification establishes that investor protections typically associated with bank deposits do not apply. The unsecured nature of the notes means that in a bankruptcy or insolvency scenario, noteholders would rank alongside other unsecured creditors of the issuer and guarantor, without preferential claims against specific assets.

Regulatory Filing Status and Distribution Framework

The pricing supplement is filed under Securities Act registration statement numbers 333-293684 and 333-293684-01, with the supplement itself designated under Rule 424(b)(2) as a pricing-related disclosure document. The preliminary nature of the supplement, dated July 23, 2026, indicates that it was issued prior to final pricing of the notes. The disclosure incorporates by reference product supplement number 3-I dated April 17, 2026, underlying supplement number 1-I dated April 17, 2026, and prospectus and prospectus supplement each dated April 17, 2026, establishing a comprehensive disclosure framework across multiple documents.

The SEC disclaimer in the disclosure explicitly states that neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved the notes or evaluated the accuracy or adequacy of the pricing supplement and accompanying materials. The disclaimer also notes that any representation to the contrary constitutes a criminal offense. This language underscores that SEC review does not constitute endorsement of the product's suitability or risk profile for any particular investor class.